Regeneron Pharmaceuticals
REGN
#286
Rank
S$100.57 B
Marketcap
S$951.37
Share price
-2.51%
Change (1 day)
12.05%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : S$11.99 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's total liabilities are S$11.99 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regeneron Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$11.94 B4.52%
2024-12-31S$11.42 B21.73%
2023-12-31S$9.38 B6.89%
2022-12-31S$8.78 B-2.55%
2021-12-31S$9.01 B10.98%
2020-12-31S$8.12 B62.11%
2019-12-31S$5.00 B23.16%
2018-12-31S$4.06 B16.06%
2017-12-31S$3.50 B-4.07%
2016-12-31S$3.65 B32.16%
2015-12-31S$2.76 B62.51%
2014-12-31S$1.70 B34.41%
2013-12-31S$1.26 B23.93%
2012-12-31S$1.02 B-5.88%
2011-12-31S$1.08 B49.99%
2010-12-31S$0.72 B49.61%
2009-12-31S$0.48 B11.7%
2008-12-31S$0.43 B-36.8%
2007-12-31S$0.68 B21.23%
2006-12-31S$0.56 B9.64%
2005-12-31S$0.51 B8.71%
2004-12-31S$0.47 B-18.4%
2003-12-31S$0.58 B36.32%
2002-12-31S$0.42 B0.5%
2001-12-31S$0.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
S$151.74 B 1,164.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$83.05 B 592.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
S$105.65 B 780.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$83.46 B 595.80%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$14.42 B 20.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$5.38 B-55.09%๐Ÿ‡บ๐Ÿ‡ธ USA